Emerging role of stereotactic radiotherapy (SRT) in the treatment of early stage non-small cell lung cancer

Joshua D. Lawson, Ajay Sandhu, Steve Jiang, Arno J. Mundt

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Patients with early stage non small cell lung cancer (NSCLC) have historically been treated by resection alone, with results that have been superior to the results seen with radiation alone. This reflects the selection bias inherent to any comparison of operative and non-operative patients but surgery remains preferred treatment option. However, relapse rate after surgery is significant. In addition, a large proportion of these patients are not amenable to surgery due to medical co-morbidities and co-existing illnesses. These patients typically undergo a course of conventional radiotherapy, which provides poor outcomes both in terms of local control and survival. Attempts at dose escalation have met with some success, but local failures remain common and further dose escalation is limited by unacceptable toxicities. SRT allows for the delivery of a very high dose of radiation to a precise target. SRT presents the challenge of organ motion throughout the respiratory cycle. We review methods to mitigate this problem using both frame-based and frameless techniques, implanted fiducial markers, respiratory gating or deep inspiratory breath hold, and image guidance. Clinical experience with lung SRT continues to grow. Toxicities have been surprisingly mild. Based on available evidence, SRT appears to be effective, convenient and well tolerated.

Original languageEnglish (US)
Pages (from-to)281-287
Number of pages7
JournalCurrent Cancer Therapy Reviews
Volume5
Issue number4
DOIs
StatePublished - 2009

Fingerprint

Non-Small Cell Lung Carcinoma
Radiotherapy
Fiducial Markers
Radiation
Therapeutics
Selection Bias
Morbidity
Recurrence
Lung
Survival

Keywords

  • Body radiosurgery
  • Extracranial radiosurgery
  • Lung cancer
  • Non small cell
  • Radiosurgery

ASJC Scopus subject areas

  • Oncology
  • Cancer Research
  • Molecular Medicine

Cite this

Emerging role of stereotactic radiotherapy (SRT) in the treatment of early stage non-small cell lung cancer. / Lawson, Joshua D.; Sandhu, Ajay; Jiang, Steve; Mundt, Arno J.

In: Current Cancer Therapy Reviews, Vol. 5, No. 4, 2009, p. 281-287.

Research output: Contribution to journalArticle

@article{5249c067535a4129a3ffea62859109ac,
title = "Emerging role of stereotactic radiotherapy (SRT) in the treatment of early stage non-small cell lung cancer",
abstract = "Patients with early stage non small cell lung cancer (NSCLC) have historically been treated by resection alone, with results that have been superior to the results seen with radiation alone. This reflects the selection bias inherent to any comparison of operative and non-operative patients but surgery remains preferred treatment option. However, relapse rate after surgery is significant. In addition, a large proportion of these patients are not amenable to surgery due to medical co-morbidities and co-existing illnesses. These patients typically undergo a course of conventional radiotherapy, which provides poor outcomes both in terms of local control and survival. Attempts at dose escalation have met with some success, but local failures remain common and further dose escalation is limited by unacceptable toxicities. SRT allows for the delivery of a very high dose of radiation to a precise target. SRT presents the challenge of organ motion throughout the respiratory cycle. We review methods to mitigate this problem using both frame-based and frameless techniques, implanted fiducial markers, respiratory gating or deep inspiratory breath hold, and image guidance. Clinical experience with lung SRT continues to grow. Toxicities have been surprisingly mild. Based on available evidence, SRT appears to be effective, convenient and well tolerated.",
keywords = "Body radiosurgery, Extracranial radiosurgery, Lung cancer, Non small cell, Radiosurgery",
author = "Lawson, {Joshua D.} and Ajay Sandhu and Steve Jiang and Mundt, {Arno J.}",
year = "2009",
doi = "10.2174/157339409789712636",
language = "English (US)",
volume = "5",
pages = "281--287",
journal = "Current Cancer Therapy Reviews",
issn = "1573-3947",
publisher = "Bentham Science Publishers B.V.",
number = "4",

}

TY - JOUR

T1 - Emerging role of stereotactic radiotherapy (SRT) in the treatment of early stage non-small cell lung cancer

AU - Lawson, Joshua D.

AU - Sandhu, Ajay

AU - Jiang, Steve

AU - Mundt, Arno J.

PY - 2009

Y1 - 2009

N2 - Patients with early stage non small cell lung cancer (NSCLC) have historically been treated by resection alone, with results that have been superior to the results seen with radiation alone. This reflects the selection bias inherent to any comparison of operative and non-operative patients but surgery remains preferred treatment option. However, relapse rate after surgery is significant. In addition, a large proportion of these patients are not amenable to surgery due to medical co-morbidities and co-existing illnesses. These patients typically undergo a course of conventional radiotherapy, which provides poor outcomes both in terms of local control and survival. Attempts at dose escalation have met with some success, but local failures remain common and further dose escalation is limited by unacceptable toxicities. SRT allows for the delivery of a very high dose of radiation to a precise target. SRT presents the challenge of organ motion throughout the respiratory cycle. We review methods to mitigate this problem using both frame-based and frameless techniques, implanted fiducial markers, respiratory gating or deep inspiratory breath hold, and image guidance. Clinical experience with lung SRT continues to grow. Toxicities have been surprisingly mild. Based on available evidence, SRT appears to be effective, convenient and well tolerated.

AB - Patients with early stage non small cell lung cancer (NSCLC) have historically been treated by resection alone, with results that have been superior to the results seen with radiation alone. This reflects the selection bias inherent to any comparison of operative and non-operative patients but surgery remains preferred treatment option. However, relapse rate after surgery is significant. In addition, a large proportion of these patients are not amenable to surgery due to medical co-morbidities and co-existing illnesses. These patients typically undergo a course of conventional radiotherapy, which provides poor outcomes both in terms of local control and survival. Attempts at dose escalation have met with some success, but local failures remain common and further dose escalation is limited by unacceptable toxicities. SRT allows for the delivery of a very high dose of radiation to a precise target. SRT presents the challenge of organ motion throughout the respiratory cycle. We review methods to mitigate this problem using both frame-based and frameless techniques, implanted fiducial markers, respiratory gating or deep inspiratory breath hold, and image guidance. Clinical experience with lung SRT continues to grow. Toxicities have been surprisingly mild. Based on available evidence, SRT appears to be effective, convenient and well tolerated.

KW - Body radiosurgery

KW - Extracranial radiosurgery

KW - Lung cancer

KW - Non small cell

KW - Radiosurgery

UR - http://www.scopus.com/inward/record.url?scp=71749100870&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=71749100870&partnerID=8YFLogxK

U2 - 10.2174/157339409789712636

DO - 10.2174/157339409789712636

M3 - Article

AN - SCOPUS:71749100870

VL - 5

SP - 281

EP - 287

JO - Current Cancer Therapy Reviews

JF - Current Cancer Therapy Reviews

SN - 1573-3947

IS - 4

ER -